Sanofi
Breakthrough T1D partner since 2020
Sanofi has been a leader in developing innovative medicines and tools for people with diabetes for over 100 years.
Since launching its first insulin in 1923, Sanofi has been at the forefront of diabetes management. Today, Sanofi offers the first FDA-approved therapy, Tzield, to delay the full onset of T1D.
About the partnership
Sanofi is a proud sponsor of Breakthrough T1D’s Early Detection program, increasing knowledge and awareness of the ability to identify early stages of T1D before symptoms develop. Sanofi also proudly supports Breakthrough T1D Community Summits, and is a member of Breakthrough T1D’s Industry Advisory Panel (IAP).
Through all aspects of this partnership, Sanofi supports Breakthrough T1D’s mission to drive cures and life-changing advances for people affected by T1D.
Become a corporate partner
Strengthen brand loyalty. Engage and empower employees. Champion health equity.
With your support, we are creating a movement to improve and change life with T1D, advancing breakthroughs on the way to cure the condition.
Contact us!
Organizations and companies interested in exploring a Breakthrough T1D corporate partnership can start the conversation by filling out a short online form. We look forward to hearing from you!
Learn about workplace giving
Workplace giving campaigns provide employees with a convenient way to support Breakthrough T1D. We offer several options for private and public sector organizations, including our popular matching gifts program!
Fundraise with us
Walk. Ride. Run. Gala. Golf. Play. Or create your own way! Learn about our fundraising programs and how your organization and employees can participate!
